Prozac, a commonly prescribed medication for kids and teens with autism, is no more effective than a placebo at treating obsessive-compulsive behaviors, a small study finds.

The results of the randomized clinical trial, published October 22 in JAMA, cast further doubt on the widespread practice of prescribing a class of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, to treat children with autism who have these behaviors, says pediatric neurologist Ann Neumeyer.

View Full Article

You need to login or register to bookmark/favorite this content.